3-n-butylphthalide has been researched along with ALS - Amyotrophic Lateral Sclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, BM; Browne, EC | 1 |
| Cui, L; Fan, D; He, J; Huang, X; Liu, M; Shang, H; Yao, X | 1 |
| Cui, L; Feng, X; Liu, M; Peng, Y | 1 |
| Cui, LY; Feng, XH; Liu, MS; Peng, Y; Yuan, W | 1 |
1 review(s) available for 3-n-butylphthalide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting.
Topics: Amyotrophic Lateral Sclerosis; Animals; Biological Products; Disease Models, Animal; Drug Discovery; Humans; Mice; Superoxide Dismutase-1 | 2016 |
1 trial(s) available for 3-n-butylphthalide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Benzofurans; Double-Blind Method; Humans; Treatment Outcome | 2023 |
2 other study(ies) available for 3-n-butylphthalide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Benzofurans; Disease Models, Animal; Mice; Mice, Transgenic; Motor Neurons; Neuroglia; Neuroprotective Agents; Spinal Cord; Superoxide Dismutase | 2012 |
Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Benzofurans; Disease Models, Animal; Female; Immunohistochemistry; Mice; Mice, Transgenic | 2012 |